<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="2" iati-activities:version="2.03" xml:lang="EN" xmlns:gavi="http://gavi.org/" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>47122-AFG-TCA</iati-identifier>
  <reporting-org ref="47122" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="FR">Afghanistan (l&apos;): Aide cibl&#xE9;e aux pays</narrative>
   <narrative xml:lang="EN">Afghanistan: Targeted country assistance</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">Plans d&#x2019;assistance technique cibl&#xE9;e aux pays L&#x2019;assistance technique cibl&#xE9;e aux pays (TCA) est octroy&#xE9;e sous forme de ressources destin&#xE9;es aux partenaires pr&#xE9;sents dans les pays. La TCA est un &#xE9;l&#xE9;ment du cadre d&#x2019;engagement avec les partenaires (PEF) de Gavi. Le plan de TCA d&#x2019;un pays est &#xE9;tablie selon les besoins exprim&#xE9;s du dit pays lors de l&#x2019;&#xE9;valuation conjointe. Un plan comprend une liste d&#x2019;activit&#xE9;s, d&#x2019;&#xE9;tapes cl&#xE9;s, et un budget pour une ann&#xE9;e dite.  L&#x2019;assistance technique est un soutien non financier fourni par des sp&#xE9;cialistes. Elle peut rev&#xEA;tir plusieurs formes : partage d&#x2019;information et de savoir-faire, formation et services-conseils.

L&#x2019;assistance technique fournie dans le cadre du PEF est appel&#xE9;e aide cibl&#xE9;e aux pays. Ce type de soutien vise principalement &#xE0; payer le personnel bas&#xE9; en permanence dans les bureaux pays des partenaires. Il repose sur la demande et les besoins identifi&#xE9;s par les pays eux-m&#xEA;mes.</narrative>
   <narrative xml:lang="EN">Targeted country assistance (TCA) are resources provided to in-country partners under Gavi&#x2019;s partners&#x2019; engagement framework (PEF). A country&#x2019;s TCA plan is based on needs expressed by the country during the joint appraisal discussions. It includes sets of activities, milestones and budget for a given year.Technical assistance is non-financial support provided by specialists. It can take the form of sharing information and expertise, training and consulting services.

The technical assistance provided through PEF is called targeted country assistance (TCA). This type of support mainly consists of staff permanently based in partners&#x2019; country offices. It is based on the demand and needs identified by the countries themselves.</narrative>
  </description>
  <participating-org role="4" type="70">
   <narrative xml:lang="EN">Acasus</narrative>
  </participating-org>
  <participating-org ref="47122" role="1" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org ref="47122" role="3" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org role="4" type="10">
   <narrative xml:lang="EN">The Government of Afghanistan</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-41122" role="4" type="40">
   <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
  </participating-org>
  <participating-org ref="XI-GRID-grid.5510.1" role="4" type="80">
   <narrative xml:lang="EN">University of Oslo</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-928" role="4" type="40">
   <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
  </participating-org>
  <other-identifier ref="47122" type="B1">
   <owner-org ref="47122">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </owner-org>
  </other-identifier>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2019-01-01" type="1"></activity-date>
  <activity-date iso-date="2019-01-01" type="2"></activity-date>
  <activity-date iso-date="2022-12-31" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </organisation>
   <email>info@gavi.org</email>
   <website>http://www.gavi.org/</website>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="AF" percentage="100"></recipient-country>
  <location>
   <location-reach code="1"></location-reach>
   <location-id code="AF" vocabulary="A4"></location-id>
   <name>
    <narrative xml:lang="EN">Kabul</narrative>
   </name>
   <administrative code="AF" vocabulary="A4"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>34.52813 69.17233</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="2"></location-class>
  </location>
  <sector code="TCA" percentage="100" vocabulary="99">
   <narrative xml:lang="EN">Targeted country assistance</narrative>
  </sector>
  <sector code="12250" percentage="100" vocabulary="1"></sector>
  <tag code="1" vocabulary="2"></tag>
  <tag code="10" vocabulary="2"></tag>
  <tag code="11" vocabulary="2"></tag>
  <tag code="13" vocabulary="2"></tag>
  <tag code="16" vocabulary="2"></tag>
  <tag code="17" vocabulary="2"></tag>
  <tag code="2" vocabulary="2"></tag>
  <tag code="3" vocabulary="2"></tag>
  <tag code="4" vocabulary="2"></tag>
  <tag code="5" vocabulary="2"></tag>
  <tag code="7" vocabulary="2"></tag>
  <tag code="8" vocabulary="2"></tag>
  <tag code="9" vocabulary="2"></tag>
  <policy-marker code="1" significance="2" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="2" vocabulary="1"></policy-marker>
  <collaboration-type code="2"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2019-01-01"></period-start>
   <period-end iso-date="2019-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">1773386</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-01-01"></period-start>
   <period-end iso-date="2020-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">3558704</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">2856497</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">453182</value>
  </budget>
  <capital-spend percentage="0"></capital-spend>
  <transaction ref="AFGPEF-TCA-ACASUS2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">233236</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="AFGPEF-TCA-GDS2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">126291</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-GDS</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="AFGPEF-TCA-UNI OF OSLO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">8594</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="AFGPEF-TCA-UNIC2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">735980</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="AFGPEF-TCA-WHO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">669285</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="AFGPEF-TCA-ACASUS2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">690605</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="AFGPEF-TCA-E&amp;Y2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">17200</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-E&amp;Y</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="AFGPEF-TCA-GDS2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">98770</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-GDS</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="AFGPEF-TCA-UNI OF OSLO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">18804</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="AFGPEF-TCA-UNIC2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">1598775</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="AFGPEF-TCA-WHO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">1134551</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="AFGPEF-TCA-ACASUS2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">476915</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="AFGPEF-TCA-E&amp;Y2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">34400</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-E&amp;Y</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="AFGPEF-TCA-GDS2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">16052</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-GDS</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="AFGPEF-TCA-UNI OF OSLO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">51626</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="AFGPEF-TCA-UNIC2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">1257863</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="AFGPEF-TCA-WHO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">1019641</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="AFGPEF-TCA-UNIC2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">250926</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="AFGPEF-TCA-WHO2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">202256</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900006971">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-20"></transaction-date>
   <value currency="USD" value-date="2019-09-20">113736</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001252">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">119500</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000432">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">-119500</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000317">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-12"></transaction-date>
   <value currency="USD" value-date="2020-02-12">51433</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000318">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-12"></transaction-date>
   <value currency="USD" value-date="2020-02-12">67750</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000871">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-17"></transaction-date>
   <value currency="USD" value-date="2020-03-17">45396</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001225">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-16"></transaction-date>
   <value currency="USD" value-date="2020-04-16">67750</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002511">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-07-16"></transaction-date>
   <value currency="USD" value-date="2020-07-16">67750</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002510">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-07-16"></transaction-date>
   <value currency="USD" value-date="2020-07-16">8189</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003060">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-09-03"></transaction-date>
   <value currency="USD" value-date="2020-09-03">95840</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003777">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-09-30"></transaction-date>
   <value currency="USD" value-date="2020-09-30">95840</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003885">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-10-15"></transaction-date>
   <value currency="USD" value-date="2020-10-15">31405</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005093">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-17"></transaction-date>
   <value currency="USD" value-date="2020-12-17">95840</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-16317</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-27561</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-6354</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000008">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">16317</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000008">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">27561</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000008">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">6354</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001455">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-04-26"></transaction-date>
   <value currency="USD" value-date="2021-04-26">16192</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001292">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-04-26"></transaction-date>
   <value currency="USD" value-date="2021-04-26">95840</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003064">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-30"></transaction-date>
   <value currency="USD" value-date="2021-06-30">19036</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003034">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-30"></transaction-date>
   <value currency="USD" value-date="2021-06-30">95840</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002046">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-20"></transaction-date>
   <value currency="USD" value-date="2021-07-20">14999</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ACASUS (Acasus)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Acasus</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000991">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">46648</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GDS</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900001153">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">65085</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GDS</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900001294">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-07-31"></transaction-date>
   <value currency="USD" value-date="2019-07-31">-30055</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GDS</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900006972">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-20"></transaction-date>
   <value currency="USD" value-date="2019-09-20">15353</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GDS</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100000420">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-14"></transaction-date>
   <value currency="USD" value-date="2019-11-14">14115</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GDS</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="700001176">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">-14115</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GDS</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="700001176">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">14115</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GDS</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100000834">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-12"></transaction-date>
   <value currency="USD" value-date="2020-03-12">41171</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GDS</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100001765">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-05-04"></transaction-date>
   <value currency="USD" value-date="2020-05-04">41171</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GDS</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100002381">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-06-15"></transaction-date>
   <value currency="USD" value-date="2020-06-15">376</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GDS</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-16052</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GDS</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900000008">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">16052</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-GDS</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="700000318">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-19"></transaction-date>
   <value currency="USD" value-date="2019-11-19">7604</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001283">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">-513</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700003729">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-09-30"></transaction-date>
   <value currency="USD" value-date="2020-09-30">229170</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-09-30"></transaction-date>
   <value currency="USD" value-date="2020-09-30">804</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700003728">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-10-01"></transaction-date>
   <value currency="USD" value-date="2020-10-01">-229170</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700004272">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-10-31"></transaction-date>
   <value currency="USD" value-date="2020-10-31">229170</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700004271">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-01"></transaction-date>
   <value currency="USD" value-date="2020-11-01">-229170</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004212">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-10"></transaction-date>
   <value currency="USD" value-date="2020-11-10">2374</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-15626</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000007">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">15626</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004623">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-23"></transaction-date>
   <value currency="USD" value-date="2021-09-23">375</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000830">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">669073</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000229">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-04"></transaction-date>
   <value currency="USD" value-date="2020-02-04">66905</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000867">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-17"></transaction-date>
   <value currency="USD" value-date="2020-03-17">156117</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001481">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-14"></transaction-date>
   <value currency="USD" value-date="2020-04-14">762476</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">-66905</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">66905</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005692">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">613275</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001377">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-30"></transaction-date>
   <value currency="USD" value-date="2021-03-30">127079</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002681">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-10"></transaction-date>
   <value currency="USD" value-date="2021-06-10">752778</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000831">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">669285</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001657">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-28"></transaction-date>
   <value currency="USD" value-date="2020-04-28">631848</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005691">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">502703</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001826">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-04-27"></transaction-date>
   <value currency="USD" value-date="2021-04-27">0</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001826">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-04-27"></transaction-date>
   <value currency="USD" value-date="2021-04-27">105308</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002722">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-10"></transaction-date>
   <value currency="USD" value-date="2021-06-10">606769</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/role-expanded-partners-under-pef-guidance-note">
   <title>
    <narrative xml:lang="EN">Partners&#x2019; engagement framework (PEF)</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Guidance on the role of expanded partners in the provision of targeted country assistance</narrative>
   </description>
   <category code="A04"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/directives-concernant-le-processus-mis-en-place-au-titre-de-laide">
   <title>
    <narrative xml:lang="EN">Directives concernant le processus mis en place au titre de l&#x2019;aide cibl&#xE9;e aux pays dans le cadre du PEF</narrative>
   </title>
   <category code="A04"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-afghanistan-2017">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Afghanistan 2017</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-afghanistan-2017">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Afghanistan 2017</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-afghanistan-2018">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Afghanistan 2018</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-afghanistan-2018">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Afghanistan 2018</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-afghanistan-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Afghanistan 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-afghanistan-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Afghanistan 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-afghanistan-2020">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Afghanistan 2020</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2020-07-10"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-afghanistan-2021">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Afghanistan 2021</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2021-05-31"></document-date>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/fr/programmes-et-impact/types-de-soutien/pef">
   <title>
    <narrative xml:lang="EN">Cadre d&apos;engagement avec les partenaires</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">A travers le cadre d&#x2019;engagement avec les partenaires, les partenaires de l&#x2019;Alliance du Vaccin soutiennent les activit&#xE9;s de vaccination au niveau national</narrative>
   </description>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/types-support/pef/targeted-country-assistance">
   <title>
    <narrative xml:lang="EN">About targeted country assistance</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Gavi&#x2019;s targeted country assistance aims to share our partners&#x2019; specialist skills with the countries we support</narrative>
   </description>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/fr/types-de-soutien/pef/aide-ciblee-aux-pays">
   <title>
    <narrative xml:lang="EN">&#xC0; propos de l&#x2019;aide cibl&#xE9;e aux pays</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">L&#x2019;aide cibl&#xE9;e aux pays de Gavi vise &#xE0; partager les comp&#xE9;tences sp&#xE9;cialis&#xE9;es de nos partenaires avec les pays que nous soutenons</narrative>
   </description>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/programmes-impact/types-support/pef">
   <title>
    <narrative xml:lang="EN">Partners&apos; engagement framework</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Through the partners&#x2019; engagement framework, Vaccine Alliance partners support countries&#x2019; immunisation activities</narrative>
   </description>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <related-activity ref="47122-AFG" type="1"></related-activity>
  <conditions attached="1">
   <condition type="2">
    <narrative xml:lang="EN">Conditions are detailed in the Partners&#x2019; engagement framework</narrative>
    <narrative xml:lang="FR">Les conditions sont d&#xE9;taill&#xE9;es dans le cadre d&apos;engagement des partenaires</narrative>
   </condition>
  </conditions>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Supply Chain &amp; Procurement</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. EVM assessment completed, and comprehensive EVM improvement plans developed for five years which will be fed into the development of upcoming HSS4 proposal.
2. Functionality rate of cold chain equipment improved.
3. PSR&quot; related to Portfolio planning pertaining to cold chain developed with support from country partners.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Staff support (P3)">
      <location ref="AF"></location>
     </target>
     <actual value="On Track">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">1. EVM assessment has been completed. Report is attached. 
2. Functionality rate of cold chain increased from 93% to 94.2%. 
3. Now, the Theory of Change (ToC) is used instead of PSR. Development of ToC for cold chain is under process.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Staff support (P3)">
      <location ref="AF"></location>
     </target>
     <actual value="On Track">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">1. EVM assessment has been completed. Report is attached. 
2. Functionality rate of cold chain increased from 93% to 94.2%. 
3. Now, the Theory of Change (ToC) is used instead of PSR. Development of ToC for cold chain is under process.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Financial/General Management</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. No vaccine stock out at Regional/Provincial levels during the reporting period
2. Sickness rate of cold chain equipment is &lt;5% during the reporting period
3. Communication material updated, printed and disseminated</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="11 NTA staff: Tehnical support to data, communication, HSS, cold chain, servivice dleivery, surviellance, finance, coordination by NTAs to EPI programme through MoPH.">
      <location ref="AF"></location>
     </target>
     <actual value="Completed">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">1. No stock of routine EPI and COVID-19 vaccines has been reported during July-Nov 2021. Country experienced stock-out of COVID-19 vaccine in first half of 2021. 
2. Functionality rate of cold chain increased from 93% to 94.2%. Fresh inventory is under process, and new functionality rate will become available by end of 2021.
3. Designed, printed and distributed the following IEC materials for routine EPI: 25, 530 vaccines banners, 135,000 posters, 385,000 leaflets, 3,000 EPI stickers, 1,000 suit pitches.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Capacity of National Data team and 34 Provincial Data Officers in information collation and analysis increased.
2. COVID 19 vaccination data collection system is developed and implemented by mid 2021.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="One staff at P3: Technical support to improve quality of EPI data">
      <location ref="AF"></location>
     </target>
     <actual value="Completed">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">1. Only one training for national data team has been conducted. Other capacity building related activities did not proceed due to fragile situation in the country. 
2. COVID-19 vaccination data collection system is already in place. Data are recorded on the standard registration materials in the field (vaccination sessions), compiled and uploaded onto the DHIS2.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Demand Promotion &amp; ACSM</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. CD+ implemented in 13 low performing districts.
2. Religious leaders training completed in 25 provinces.
3. PSR&quot; related to Portfolio planning pertaining to demand generation developed with support from country partners.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Staff support (NO-B)">
      <location ref="AF"></location>
     </target>
     <actual value="Completed">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">1. CD+ project was completed in April 2021. The project extended for another three months (by end of July 2021) upon request of MoPH to make sure optimal result is achieved. Evaluation by third party is under contract process.
2. Reported earlier; religious leaders? training has been completed in 2020 and a total of 13,730 religious scholars received training across the country. 
3. Human Centered Designed Approach study has been conducted and results fed into Theory of Change. ToC reports for demand are attached.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Staff support (NO-B)">
      <location ref="AF"></location>
     </target>
     <actual value="Completed">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">1. CD+ project was completed in April 2021. The project extended for another three months (by end of July 2021) upon request of MoPH to make sure optimal result is achieved. Evaluation by third party is under contract process.
2. Reported earlier; religious leaders? training has been completed in 2020 and a total of 13,730 religious scholars received training across the country. 
3. Human Centered Designed Approach study has been conducted and results fed into Theory of Change. ToC reports for demand are attached.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Communication materials designed, developed and broadcasted for COVID-19 vaccination programme.
2. Perception study on COVID-19 vaccine conducted.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="One staff at NOB: Technical suppor to demand generation related interventions">
      <location ref="AF"></location>
     </target>
     <actual value="Completed">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">1. Specifically using the PEF/TCA, 12,600 IPCI and EPI communication training guideline and COVID-19 vaccine Q&amp;A booklet have been printed, nine IPCI training manuals and video job aids have been translated into local languages, seven IPCI video training clips have been dubbed. The incumbent C4D officer financed by PEF/TCA has also managed for COVID-19 vaccination related communication work using other funding sources as follows: designing and printing of additional IPCI and EPI communication materials and job aids, production of 8 COVID-19 TV and radio spots and animation clips, production of 6 religious scholars? messages on COVID-19 for TV and radio, insertion of 5,787 TV and 11,130 radio messages on importance of COVID-19 vaccine, arrangement/rollout of one advocacy event on COVID-19 vaccine, installation of 20 billboards on COVID-19 vaccinations, preparation for edutainment and promotion of COVID-19 vaccination through social media. 
Furthermore, designed, printed and distributed the following IEC materials for COVID-19 vaccinations: 5,000 banners, 12,000 posters, 100,000 leaflets, 74 standees, and 10,000 suit pitches. 
2. Formative study on perception on COVID-19 vaccine has been completed. Report is attached. Well-designed version is under process and will be shared later.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Programme Management - LMC</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Installed 300 SDDs and 100 electrict refregerators (CCEOP).
2. 14 EPI buildings (warehouses and cold rooms) constructed.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="National Technical Assistance (NTA) through MoPH">
      <location ref="AF"></location>
     </target>
     <actual value="On Track">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">1. During first six months of 2021, under CCEOP project/grant a total of 190 SDDs and 136 electric refrigerators have been installed. 
2. During reporting period, 4 buildings (one regional warehouse and 3 provincial vaccine stores in next few days) have been completed and now in use. Two buildings are currently under construction. In general, a total of 23 buildings have been completed.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="National Technical Assistance (NTA) through MoPH">
      <location ref="AF"></location>
     </target>
     <actual value="On Track">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">1. During first six months of 2021, under CCEOP project/grant a total of 190 SDDs and 136 electric refrigerators have been installed. 
2. During reporting period, 4 buildings (one regional warehouse and 3 provincial vaccine stores in next few days) have been completed and now in use. Two buildings are currently under construction. In general, a total of 23 buildings have been completed.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Installed 250 SDDs (CCEOP) 2. Regularize supply delivery at sub-national level</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="National Technical Assistance (NTA) through MoPH">
      <location ref="AF"></location>
     </target>
     <actual value="On Track">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">1. Under CCEOP project/grant, in total 353 refrigerators (136 electric and 217 SDDs) have been installed. 
2. Supply delivery at sub-national level has been regularized.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Installed 300 SDDs and 100 electrict refregerators (CCEOP). 2. Conducted temperature mapping in all Walk-in cold rooms in one national and 7 regions. 3. Training manual for vaccine management and cold chain available.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Staff support (P3)">
      <location ref="AF"></location>
     </target>
     <actual value="Major Delays">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">1. Under CCEOP project/grant, in total 353 refrigerators (136 electric and 217 SDDs) have been installed. 
2. Temperature mapping is not yet conducted. 
3. Training manual for vaccine management and cold chain are not yet developed.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Programme Management - LMC</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">500 copies of each of seven guidelines are printed and distributed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Print /distribute latest WHO global policy documents, guidelines and manuals on RI and vaccine preventable diseases surveillance">
      <location ref="AF"></location>
     </target>
     <actual value="Completed">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">28 updated EPI and VPD surveillance related documents printed (500 sets) and distributed to the public health departments, BPHS and Non BPHS and EPI partners and used during the training sessions.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Print /distribute latest WHO global policy documents, guidelines and manuals on RI and vaccine preventable diseases surveillance">
      <location ref="AF"></location>
     </target>
     <actual value="Completed">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">28 updated EPI and VPD surveillance related documents printed (500 sets) and distributed to the public health departments, BPHS and Non BPHS and EPI partners and used during the training sessions.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">NITAG meetings and VPD surveillance review meeting conducted HSS4 application submitted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical assistance in organizing NITAG meetings,MR/CRS expert committee meetings, Rotavirus/intussucception expert committee meetings">
      <location ref="AF"></location>
     </target>
     <actual value="On Track">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">Only the surveillance review meeting could be conducted and HSS4 application is in progress and the next NITAG meeting is scheduled in July 2021.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical assistance in organizing NITAG meetings,MR/CRS expert committee meetings, Rotavirus/intussucception expert committee meetings">
      <location ref="AF"></location>
     </target>
     <actual value="On Track">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">Only the surveillance review meeting could be conducted and HSS4 application is in progress and the next NITAG meeting is scheduled in July 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">PoAs based on review and assessment developed for improving coverage and equity</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conductl EPI comprehensive review Plus immunization missed opportunity assessment">
      <location ref="AF"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">Guideline, questionaires and tools had been adopted/developped, translated into local language and printed. But due to covid-19 pandimic it was postponed and fund was transferred to Covid 16 control programs.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conductl EPI comprehensive review Plus immunization missed opportunity assessment">
      <location ref="AF"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">The routine immunization plan of action for increasing coverage and equity was developed in Jan 2021. The comprehensive EPI review and MOV is pending because of restriction due to active fighting in many parts of the country and frequent lockdown because of COVID19. Please note that the protocols, questionaries&apos; and tools are already developed and translated into local languages.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conductl EPI comprehensive review Plus immunization missed opportunity assessment">
      <location ref="AF"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">The routine immunization plan of action for increasing coverage and equity was developed in Jan 2021. The comprehensive EPI review and MOV is pending because of restriction due to active fighting in many parts of the country and frequent lockdown because of COVID19. Please note that the protocols, questionaries&apos; and tools are already developed and translated into local languages.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">National and sub-national data managers trained on use of DHIS2 with focus on immunization.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Staff support (P3)">
      <location ref="AF"></location>
     </target>
     <actual value="Completed">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">A total of 35 provincial data officers (one per province, 2 in Kabul) have been trained on use of DHIS2, focusing on immunization for one week by HMIS department of MoPH in coordination with NEPI department.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Staff support (P3)">
      <location ref="AF"></location>
     </target>
     <actual value="Completed">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">A total of 35 provincial data officers (one per province, 2 in Kabul) have been trained on use of DHIS2, focusing on immunization for one week by HMIS department of MoPH in coordination with NEPI department.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Clinical serum samples are collected and delivered to the lab</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct Hepatitis B serosurvey to establish a baseline">
      <location ref="AF"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">Activity was canceled.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Application for MSIAs is developped and submitted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support in developing application for nationwide measles SIAs in 2022">
      <location ref="AF"></location>
     </target>
     <actual value="Completed">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">Appication for 2022 national measles SIAs developed by WHO CO in consultation with MOPH, UNICEF CO, UNICEF ROSA, WHO EMRO and HQ and local partners. The NTCC reviewed and finalized in July 2021. Because of political changes in the country, and it took long time to get the signatures of authorities from MOPH and MOF. Finally, on 5th Nov both Ministry put their signatures and submitted to GAVI.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Application for MR introduction is developped and submitted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assist NIP/MOPH in developing application for introduction of combined Rubella with Measles vaccine">
      <location ref="AF"></location>
     </target>
     <actual value="Completed">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">Application submitted. MR Application uploaded to first milestone &quot;Application for MSIAs is developed and submitted.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">An national/ internation consultant is recruited to assist in developing application</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA/ consultant for introduction of HPV vaccine">
      <location ref="AF"></location>
     </target>
     <actual value="Major Delays">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">So far under negotiation with MOPH</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">A national team of experts are organized to take part and application development and the epidemiological data of measles are analylized for target setting.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support in developing application for nationwide measles SIAs in 2022">
      <location ref="AF"></location>
     </target>
     <actual value="On Track">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">The recruitment of consultant is in progress.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Application is submitted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA/ consultant for introduction of HPV vaccine">
      <location ref="AF"></location>
     </target>
     <actual value="Major Delays">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">This activity is postponed because of other priority and urgent activities.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA/ consultant for introduction of HPV vaccine">
      <location ref="AF"></location>
     </target>
     <actual value="Major Delays">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">This activity is postponed because of other priority and urgent activities.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA/ consultant for introduction of HPV vaccine">
      <location ref="AF"></location>
     </target>
     <actual value="Completed">
      <location ref="AF"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">A national team of experts are organized to take part and application development and the epidemiological data and burden of disease are analylized for target setting.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assist NIP/MOPH in developing application for introduction of combined Rubella with Measles vaccine">
      <location ref="AF"></location>
     </target>
     <actual value="On Track">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">This activity is under negotiation with MOPH and GAVI</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Programme Implementation/Coverage &amp; Equity</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% staff are selected and trained on Hep B sero-survey</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct Hepatitis B serosurvey to establish a baseline">
      <location ref="AF"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">Because of the sero survey cancelation the plan activity couldn&apos;t take place.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">All 7 VPD labs are provided with necessary logistics including diagnostic kits.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Logistical support to 7 Labs/hospitals for continuance of Rotavirus /intussusception surveillance">
      <location ref="AF"></location>
     </target>
     <actual value="On Track">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">Logisitcal support by WHO is going on to all 9 labs.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Logistical support to 7 Labs/hospitals for continuance of Rotavirus /intussusception surveillance">
      <location ref="AF"></location>
     </target>
     <actual value="On Track">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">Logisitcal support by WHO is going on to all 9 labs.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Logistical support to 7 labs/hospital for continuation of MR/CRS surveillance">
      <location ref="AF"></location>
     </target>
     <actual value="On Track">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">The VPD surveillance with lab support is functional through 9 children hospitals in Labs including 7 regional labs. WHO is providing technical logistic and performance based incentive to all surveillance staff in 9 hospitals in Labs, its because the VPD surveillance is not included into the routine activities of hospitals, the diagnosis is taking place based on clinical symptoms; therefore, WHO is providing incentive to surveillance lab staff to be engaged in VPD surveillance after official working hours. Based on the needs of laboratories WHO provided equipment and supplies to all labs including IT equipment.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Logistical support to 7 labs/hospital for continuation of MR/CRS surveillance">
      <location ref="AF"></location>
     </target>
     <actual value="On Track">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">The VPD surveillance with lab support is functional through 9 children hospitals in Labs including 7 regional labs. WHO is providing technical logistic and performance based incentive to all surveillance staff in 9 hospitals in Labs, its because the VPD surveillance is not included into the routine activities of hospitals, the diagnosis is taking place based on clinical symptoms; therefore, WHO is providing incentive to surveillance lab staff to be engaged in VPD surveillance after official working hours. Based on the needs of laboratories WHO provided equipment and supplies to all labs including IT equipment.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Delivered implementation of the refresher training courses for 450 vaccinators under 50%HSS Flex grant</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA / EPI National Technical Officer">
      <location ref="AF"></location>
     </target>
     <actual value="On Track">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">Refresher training courses for 450 immunization health workers in progress and its expected to complete by end of August 2021.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA / EPI National Technical Officer">
      <location ref="AF"></location>
     </target>
     <actual value="On Track">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">Refresher training courses for 450 immunization health workers in progress and its expected to complete by end of August 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">AEFI reporting is monitored on the monthly basis; implementation of the sentinel surveillance for MR/CRS/NNT/Rotavirus is monitored regularly</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA / EPI/VPD Program Officer">
      <location ref="AF"></location>
     </target>
     <actual value="On Track">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">The WHO technical officer for VPD surveillance including AEFI together with National Surveillance officer are responsible to coordinate, organize quarterly review meeting, carry out field visits for monitoring of surveillance and managed logistics system of surveillance systems.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA / EPI/VPD Program Officer">
      <location ref="AF"></location>
     </target>
     <actual value="On Track">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">The WHO technical officer for VPD surveillance including AEFI together with National Surveillance officer are responsible to coordinate, organize quarterly review meeting, carry out field visits for monitoring of surveillance and managed logistics system of surveillance systems.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Quarterly, semi-annual and annual Sehatmandi review reports 2. National health polict 2021-25 3. HSS 4 application is submitted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA / HSS National Technical Officer">
      <location ref="AF"></location>
     </target>
     <actual value="On Track">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">The development of HSS4 proposal is on progress and its expected to submit application to GAVI by the end of Jul 2021.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA / HSS National Technical Officer">
      <location ref="AF"></location>
     </target>
     <actual value="On Track">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">The development of HSS4 proposal is on progress and its expected to submit application to GAVI by the end of Jul 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Financial support provided for administration of all activities and organization of meetings/assessments Financial reports submitted in due time</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="EPI Admin/finance assistant">
      <location ref="AF"></location>
     </target>
     <actual value="On Track">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">The position of Finance Assistant for EPI and VPD surveillance is occupied and responsible to carry out mentioned activities reflected in his ToRs.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="EPI Admin/finance assistant">
      <location ref="AF"></location>
     </target>
     <actual value="On Track">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">The position of Finance Assistant for EPI and VPD surveillance is occupied and responsible to carry out mentioned activities reflected in his ToRs.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Administrative support provided to all WHO meetings and activities GAVI meetings and relevant assessments Manage all procurement for RI and VPD surveillance Organize printing and distribution of all EPI and VPD surveillance documents p[rovide 100% support in conducting all RI and VPD surveillance trainings faciltate NITAG meetings and other forim Assist in arranging GAVI workshops, JA, and etc including hotel and travel arrangements</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA/EPI program assistant">
      <location ref="AF"></location>
     </target>
     <actual value="On Track">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">The position of Program Assistant for EPI and VPD surveillance is occupied and responsible to carry out mentioned activities reflected in his ToRs.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA/EPI program assistant">
      <location ref="AF"></location>
     </target>
     <actual value="On Track">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">The position of Program Assistant for EPI and VPD surveillance is occupied and responsible to carry out mentioned activities reflected in his ToRs.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">the remaining 50% of staff are trained</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Train 100 surveillance staff on Vaccines/biological registration post marketing surveillance (AEFI) and VPD surveillance and establishment of AEFI case investigation teams at provincial level">
      <location ref="AF"></location>
     </target>
     <actual value="Completed">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">The remaining 86 staff got 3 days training on the mentioned topics.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Train 100 surveillance staff on Vaccines/biological registration post marketing surveillance (AEFI) and VPD surveillance and establishment of AEFI case investigation teams at provincial level">
      <location ref="AF"></location>
     </target>
     <actual value="Completed">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">The remaining 86 staff got 3 days training on the mentioned topics.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">the final report on sero-survey is submitted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct Hepatitis B serosurvey to establish a baseline">
      <location ref="AF"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">This activity was canceled by MOPH and GAVI has kindly agreed to transfer the planned fund for COVID19 related activities.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct Hepatitis B serosurvey to establish a baseline">
      <location ref="AF"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">This activity was canceled by MOPH and GAVI has kindly agreed to transfer the planned fund for COVID19 related activities.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% of trained staff are engaged in planning, implementation and monitoring of vaccination in emergencies</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct vaccination in humanitarian emergencies">
      <location ref="AF"></location>
     </target>
     <actual value="On Track">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">Yes, all the health workers are/were engaged in planning, communicating, implementing and monitoring/reporting of PIRI. the last two rounds of PIRI is going in two provinces and the remaining already completed.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct vaccination in humanitarian emergencies">
      <location ref="AF"></location>
     </target>
     <actual value="On Track">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">Yes, all the health workers are/were engaged in planning, communicating, implementing and monitoring/reporting of PIRI. the last two rounds of PIRI is going in two provinces and the remaining already completed.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Supply chain</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">EVM improving plan developed for next five year.
Cold chain capacity assesmet completed for COVID-19 vaccine introduction.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="One staff at P3: Technical support to strenghten EPI supply and cold chain system">
      <location ref="AF"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">EVM improvement plan is under process and not yet developed.
Cold chain assessment has been completed already and is reflected in the National Vaccine Deployment Plan (NVDP). Country</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Programme Implementation/Coverage &amp; Equity</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">120 EPI staff (managers and supervisors) at the national and sub-national level trained on IPC</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="IPCI training for EPI managers, supervisors and frontline health workers">
      <location ref="AF"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">IPC training module has been contextualized and converted/developed into Inter-personal Communication for Immunization (IPCI) module. The module has been designed and translated into local languages, printed, and video job aids have been dubbed into local languages. Implementation of the training is re-programmed by MoPH due to COVID-19 uncertain situation. The allocation of IPCI training will be spent in support of ACASUS-run project around EPI performance. Gavi agreed to this change.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="IPCI training for EPI managers, supervisors and frontline health workers">
      <location ref="AF"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">IPC training module has been contextualized and converted/developed into Inter-personal Communication for Immunization (IPCI) module. The module has been designed and translated into local languages, printed, and video job aids have been dubbed into local languages. Implementation of the training is re-programmed by MoPH due to COVID-19 uncertain situation. The allocation of IPCI training will be spent in support of ACASUS-run project around EPI performance. Gavi agreed to this change.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Leadership, management, and coordination (LMC)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The annual plan of actions is approved</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In close coordination with NIP and BPHS NGOs to conduct need assessment for planning refresher training courses on RI and facilitate training sessions; plan and conduct trainin courses on accelerated immunization activities, assist NIP in training of staff on Measles SIAs, introduction of new vaccine; develop training materials on different aspects of RI including EVMA, EPI review, DQs, coverage survey and annual review of national immunization programs and conduct field monitoring">
      <location ref="AF"></location>
     </target>
     <actual value="Completed">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">Because of coivid 19 pandemic some activities such as national EPI review, data quality audit, coverage survey, and Hep B serosurvey could not be conducted, and the fund from the 2021 work plan was transferred to Covid19 control and vaccination. The 4 rounds of accelerated immunization activities conducted in 7 provinces out of 10 because of continuous conflicts. Afghanistan is not eligible for introduction of new vaccines because of</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assist in planning, budgeting, procurement, receving and distribution of lab reagents, specimen collection kits, consumable supplies, equipment, recording and reporting materials for VPD surveillance; procurement of different items for RI programs and distribution to the labs and 34 provinces; and supporing NIP in VPD surveillance data entering; perform admin and finance support.">
      <location ref="AF"></location>
     </target>
     <actual value="Completed">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">List of all items procutred and distributed is attached</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical and logistic support to MOPH by joint monthly and annual plan of actions for strenthening VPD surveillance system at all level of health system by planning/implementing training, supportive supervision, field monitoring, conducting monthly review of VPD surveillance and reporting to all partners">
      <location ref="AF"></location>
     </target>
     <actual value="Completed">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">TA/Amin/Finance support: appropriate logistics and financial facility for VPD surveillance and routine immunization, technical, administrative, financial management and good dealing with MOPH and partners provided by WHO EPI program and admin/finance assistants.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="A / HSS National Program Officer to support coordination between HSS, RI program, MoPH line departments, BPHS/EPHS implementing NGOs, other partners, and donors, with a special focus on the following:
- Contribute to the quarterly, semi-annual, and annual performance review of BPHS/EPHS implementers
- Contribute to the Full Portfolio Planning and development of PSR
- Contribute to EPI coverage survey
- Contribute to AfDHS and facilitating the inclusion of immunization related indicators
- Contribute to the introduction of COVID vaccine
- Contribute to HSS/EPI related meetings, reviews, and workshops
- Contribute to the development of new National Health Policy and Strategy and advocate for prioritizing immunization
- Contribute to Polio transition planning">
      <location ref="AF"></location>
     </target>
     <actual value="Completed">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">WHO represented in almost EPI related forums at high level of MOPH including developing MOPH annual plan of actions insisting more on immunization planning, budgetting, accountability of the governent, strong stewardship, regular monitoring of BPHS/EPHS NGO performance, and reflecting all components including high coverage and equity of immunization national health policy and annual and strategic public health plan of the ministry of public health. The recent documents were developped by WHO where EPI is give high priority.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide administrative/finacial/technical support in planning, budgeting, managing, using of resources, controlling, accounting monitoring of correct using of fund and timely reporting to the relevant partners; facilitating EPI/VPD surveillance related training courses, workshops, EPI reviews, assessments, and monitoring of using funds at sub-national level.">
      <location ref="AF"></location>
     </target>
     <actual value="On Track">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">WHO represented in almost EPI related forums at high level of MOPH including developing MOPH annual plan of actions insisting more on immunization planning, budgetting, accountability of the governent, strong stewardship, regular monitoring of BPHS/EPHS NGO performance, and reflecting all components including high coverage and equity of immunization national health policy and annual and strategic public health plan of the ministry of public health. The recent documents were developped by WHO where EPI is give high priority.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Annual detailed plan of actions are available</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="A / HSS National Program Officer to support coordination between HSS, RI program, MoPH line departments, BPHS/EPHS implementing NGOs, other partners, and donors, with a special focus on the following:
- Contribute to the quarterly, semi-annual, and annual performance review of BPHS/EPHS implementers
- Contribute to the Full Portfolio Planning and development of PSR
- Contribute to EPI coverage survey
- Contribute to AfDHS and facilitating the inclusion of immunization related indicators
- Contribute to the introduction of COVID vaccine
- Contribute to HSS/EPI related meetings, reviews, and workshops
- Contribute to the development of new National Health Policy and Strategy and advocate for prioritizing immunization
- Contribute to Polio transition planning">
      <location ref="AF"></location>
     </target>
     <actual value="On Track">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">The annual detail plan of action between WHO health system unit, line departments of MOPH , BPHS partners and other relevant organization is in place.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">TA/EPI Amin/finance assistant</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assist in planning, budgeting, procurement, receving and distribution of lab reagents, specimen collection kits, consumable supplies, equipment, recording and reporting materials for VPD surveillance; procurement of different items for RI programs and distribution to the labs and 34 provinces; and supporing NIP in VPD surveillance data entering; perform admin and finance support.">
      <location ref="AF"></location>
     </target>
     <actual value="On Track">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">The position is occupied.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The monthly and annual plan actions is dvelopped and followed in close consulation with NIP and BPHS partners</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical and logistic support to MOPH by joint monthly and annual plan of actions for strenthening VPD surveillance system at all level of health system by planning/implementing training, supportive supervision, field monitoring, conducting monthly review of VPD surveillance and reporting to all partners">
      <location ref="AF"></location>
     </target>
     <actual value="On Track">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">The position of is occupied and the activities going on according to the plan and schedule.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In close coordination with NIP and BPHS NGOs to conduct need assessment for planning refresher training courses on RI and facilitate training sessions; plan and conduct trainin courses on accelerated immunization activities, assist NIP in training of staff on Measles SIAs, introduction of new vaccine; develop training materials on different aspects of RI including EVMA, EPI review, DQs, coverage survey and annual review of national immunization programs and conduct field monitoring">
      <location ref="AF"></location>
     </target>
     <actual value="On Track">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">The position of is occupied and the activities going on according to the plan of action,</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">TA/EPI program assistant</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide administrative/finacial/technical support in planning, budgeting, managing, using of resources, controlling, accounting monitoring of correct using of fund and timely reporting to the relevant partners; facilitating EPI/VPD surveillance related training courses, workshops, EPI reviews, assessments, and monitoring of using funds at sub-national level.">
      <location ref="AF"></location>
     </target>
     <actual value="On Track">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">The position of is occupied.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Documented training courses on surveillance for focal points from 17 provinces conducted MR strategic plan developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to NIP for continuance of MR/CRS/NNT surveillance &amp; develop MR strategic plan">
      <location ref="AF"></location>
     </target>
     <actual value="Completed">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">All the planned training courses for surveillance including AEFI surveillance are conducted and completed. CRS and MR surveillance are integral part of vaccine preventable surveillance.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to NIP for continuance of MR/CRS/NNT surveillance &amp; develop MR strategic plan">
      <location ref="AF"></location>
     </target>
     <actual value="Completed">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">All the planned training courses for surveillance including AEFI surveillance are conducted and completed. CRS and MR surveillance are integral part of vaccine preventable surveillance.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">All 7 labs/hospital are monitored quarterly</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to 7 /Labs/hospitals for continuance of rotavirus surveillance and intussusception">
      <location ref="AF"></location>
     </target>
     <actual value="On Track">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">Monitoring is taking place every 2-3 months by WHO field staff and MOPH staff.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to 7 /Labs/hospitals for continuance of rotavirus surveillance and intussusception">
      <location ref="AF"></location>
     </target>
     <actual value="On Track">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">Monitoring is taking place every 2-3 months by WHO field staff and MOPH staff.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Leadership, management, and coordination (LMC)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">? Final version of monthly datapacks for new regions
? Overview and success factors for activities and responsibilities to transfer to Government during Phase III
? Revised supervisor training materials
? Quarterly progress report</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1) Drive further improvements in performance in the 17 provinces in which the program is already live. 2) Expand the program across the remaining 17 provinces. 3) Launch a pilot to monitor outreach performance in three provinces. 4) Strengthen performance management by creating new ?meeting facilitation manuals?, and developing ?best practice? case studies on improvements delivered by managers. 5)Hardwire sustainability into the approach through progressively transferring responsibilities to NEPI teams, and through developing an ?LMC implementation manual? for EPI managers.">
      <location ref="AF"></location>
     </target>
     <actual value="Completed">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">Monthly data-pack is available for 17 provinces (different regions) available. Scale-up in remaining province await new mobile phones to reach to the country (flight disruption due to situation). Mobile phones arrived Kabul on 15th Nov 2021, and scale-up will be initiated soon. Phase-wise plan is finalized and shared with Gavi already. Transfer of responsibilities take place based on the agreed plan step by step. Revised supervisory training materials are available. Quarterly reports submitted to Gavi by ACASUS.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Plan to scale-up across 17 new provinces</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1) Drive further improvements in performance in the 17 provinces in which the program is already live. 2) Expand the program across the remaining 17 provinces. 3) Launch a pilot to monitor outreach performance in three provinces. 4) Strengthen performance management by creating new ?meeting facilitation manuals?, and developing ?best practice? case studies on improvements delivered by managers. 5)Hardwire sustainability into the approach through progressively transferring responsibilities to NEPI teams, and through developing an ?LMC implementation manual? for EPI managers.">
      <location ref="AF"></location>
     </target>
     <actual value="On Track">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">This is managed by ACASUS through NEPI department of MoPH. It is a programme called Leadership Management and Coordination (LMP) focusing on EPI performance management. Scale-up plan is developed, procurement of required item (phone and top-up) have been initiated, actual scale-up will commence in July 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Human Resources for Health</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">NITAG and other technical fourm meetings</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Coordination of NITAG, TAGs, Task forces and other immunization related forums.">
      <location ref="AF"></location>
     </target>
     <actual value="Major Delays">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">NITAG and TAG meetings couldn&apos;t take place in 2021.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Coordination of NITAG, TAGs, Task forces and other immunization related forums.">
      <location ref="AF"></location>
     </target>
     <actual value="Completed">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">Task force meeting conducted bi-weekly and minutes of the meeting were followed up by taking actions where there were need. But, NEPI could not organize at least one NITAG meeting in 2021 because of security problems and emigration of core staff.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Coordination of NITAG, TAGs, Task forces and other immunization related forums.">
      <location ref="AF"></location>
     </target>
     <actual value="Completed">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">Task force meeting conducted bi-weekly and minutes of the meeting were followed up by taking actions where there were need. But, NEPI could not organize at least one NITAG meeting in 2021 because of security problems and emigration of core staff.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Training materials and tools are updated Monthly plan/schedule for filed monitoring available Monthly plan/schedule for surveillance available Monthly VPD surveillance reporting date is fixed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Build the technical capacity of of surveillance staff by training of 100 surveillance focal points at sub-national level, field visits, monitoring, regular review of VPD surveillance">
      <location ref="AF"></location>
     </target>
     <actual value="Completed">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">All the training materials for surveillance and routine immunization program are already updated and printed and distributed.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">80 surveyers/coordinators are trained</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical assistance in carrying out hospital/lab-based serosurvey">
      <location ref="AF"></location>
     </target>
     <actual value="Completed">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">Based on survey findings, the needs for six new VPD lab as part of regional lab were established, totally 82 surveillance cuardinators, nurses, lab technicians and staff CPHL, Kabul 2 chiild hodpitals and support staff were trainined on VPD surveillance</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">All the required items are provided quarterly for continuation of VPD surveillance system</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="WHO to contnue its logistic support to MOPH by providng diagnostic kits, lab supplies/equipment, recording and reporting materials for Measles cased-based, Rubella case-based , CRS case-based, Rotavirus, IBD, and intusussception surveillance for 9 hospitals and laboratories">
      <location ref="AF"></location>
     </target>
     <actual value="On Track">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">Based on the needs and the request from the labs the required equipment and supplies provided on quarterly basis and in case of shortage action is taking timely.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Protocols, tools and other documents are adapted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical assistance in carrying out hospital/lab-based serosurvey">
      <location ref="AF"></location>
     </target>
     <actual value="Completed">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">Protocol, questionaries&apos;, tools for comprehensive EPI review MOV and sero survey are in place.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">All the training materials and tools are available</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Strengthen vaccine/injection safety and AEFI surveillance by buidlding the capacity of provincial technical committess (100 medical doctors) for detection, investigation and response vaccines side effects">
      <location ref="AF"></location>
     </target>
     <actual value="Completed">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">The training materials for the mentioned activities are available and incorporated into national EPI guideline.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Quarterly provision of lab items</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="WHO to contnue its logistic support to MOPH by providng diagnostic kits, lab supplies/equipment, recording and reporting materials for Measles cased-based, Rubella case-based , CRS case-based, Rotavirus, IBD, and intusussception surveillance for 9 hospitals and laboratories">
      <location ref="AF"></location>
     </target>
     <actual value="On Track">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">Total 32 Lab technician 2 from each site (indragandi hospital, Maiwand hospital, Balkh regional hospital, Herat regional hospital, Kandahar regional hospital, Nangarhar regional hospital) and 2 new sites( Kunduz&amp; Gardiz) trained for 3 days on VPDs general procedure and 3 day on Lab specific issues in CPHL for practical work. Now the Lab technician are able to perform the Laboratory process for VPDs at regional level. VPD sample collection become easy the interval between sample collection and Lab investigation become short, in this case the surveillance indicter s for reporting/investigation of the cases improved to 80% sample condition improved about 90% and feedback on time to the EPI improved from 0 - 65% .</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">50% of planned focal points are trained 50% of field visits conducted Monthly provincial review of VPD surveillance conducted Monthly VPD surveillance data submitted Surveillance reports shared with all partners</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Build the technical capacity of of surveillance staff by training of 100 surveillance focal points at sub-national level, field visits, monitoring, regular review of VPD surveillance">
      <location ref="AF"></location>
     </target>
     <actual value="Completed">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">Total 55 EPI staff trained on AEFI surveillance (25 provincial EPI managers, BPHS implementers EPI officers, 24 regional master trainers and 6 national EPI officer from national EPI and NGOs EPI officers. The topics were (immunization &amp; immunity, AEFI case detection reporting and investigation, Role and responsibility of the partners in AEFI surveillance, Monitoring and supervision of AEFI surveillance system, communication for strengthen of AEFI surveillance and causality assessment.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">50% of the planned staff are trained</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Strengthen vaccine/injection safety and AEFI surveillance by buidlding the capacity of provincial technical committess (100 medical doctors) for detection, investigation and response vaccines side effects">
      <location ref="AF"></location>
     </target>
     <actual value="Completed">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">Total 55 EPI staff trained on AEFI surveillance (25 provincial EPI managers, BPHS implementers EPI officers, 24 regional master trainers and 6 national EPI officer from national EPI and NGOs EPI officers. The topics were (immunization &amp; immunity, AEFI case detection reporting and investigation, Role and responsibility of the partners in AEFI surveillance, Monitoring and supervision of AEFI surveillance system, communication for strengthen of AEFI surveillance and causality assessment.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Service Delivery</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">high risk districts/areas are identified based on deep analysis of RI and VPD surveillance data</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assist MOPH/BPHS implementing partners in assessment of VPD outbreaks and in emergencies and prepare plan of actions for immunization of eligible children in emergency affected areas">
      <location ref="AF"></location>
     </target>
     <actual value="On Track">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">The details analysis of sub national coverage is taking place on monthly basis and the corrective action are shared with sub national EPI management teams to take adequate action.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Assesment/training package and tools are availale</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assist MOPH/BPHS implementing partners in assessment of VPD outbreaks and in emergencies and prepare plan of actions for immunization of eligible children in emergency affected areas">
      <location ref="AF"></location>
     </target>
     <actual value="On Track">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">as planned, 34 MOPH data manager and 34 NGOs supervisors received a four day training on WHO guideline on measles investigation and outbreak response. The guidleine translated into local languages and distrbituted to all the partcipants. The MR surveillance sustem has the capacity to detect and investigated with 24 hours.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">University of Oslo : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Covid-19 digital package installed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of COVID-19 surveillance">
      <location ref="AF"></location>
     </target>
     <actual value="Completed">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">Covid Surveillance</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. EPI digital package installed
2. Data quality app installed
3. EPI legacy data migrated
4. Training given</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support transitioning to DHIS2 for EPI">
      <location ref="AF"></location>
     </target>
     <actual value="Major Delays">
      <location ref="AF"></location>
      <comment>
       <narrative xml:lang="EN">Lacking access to the system and EPI team</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Core team trained on COVID-19 digital data package and know how to use it.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of COVID-19 surveillance">
      <location ref="AF"></location>
     </target>
     <actual>
      <location ref="AF"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. EPI digital package installed 2. Data quality app installed 3. EPI legacy data migrated 4. Training given</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support transitioning to DHIS2 for EPI">
      <location ref="AF"></location>
     </target>
     <actual>
      <location ref="AF"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Transition plan for EPI in place with agreed date for end of parallel system
Costed scale up plan exist</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support transitioning to DHIS2 for EPI">
      <location ref="AF"></location>
     </target>
     <actual>
      <location ref="AF"></location>
     </actual>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
